You will not be allowed to compare more than 4 products at a time
View compareDescription
VIVIFLUX
A valuable aid in the primary and secondary prevention of central ischemic events and vascular cognitive decline.
-DHF: dihydrofolate
-THF: tetrahydrofolate
-5,10-METHF: 5,10-Methyltetrahydrofolate
-5-METHF: Methyltetrahydrofolate
-MTHFR: Methylenetetrahydrofolate reductase
-P5P: Pyridoxal-5-phosphate
-R5P: Riboflavin-5-phosphate
Folate is of fundamental importance for the conversion of homocysteine to methionine.
Methylenetetrahydrofolate reductase (MTHFR) is the limiting enzyme in the methyl cycle that catalyzes the only biochemical reaction that produces 5-methyltetrahydrofolate (Quatrefolic), useful for reducing plasma homocysteine levels.
MTHFR C677T is a common MTHFR mutation with reduced catalytic activity, which leads to elevated plasma homocysteine levels, a common risk factor for cardiovascular disorders. A recent meta-analysis (published in June 2017) observed that patients with the MTHFR C677T mutation have a 30% higher risk of developing ischemic stroke.
Ingredients
Fish oil titrated in docosahexaenoic acid (DHA), extra virgin olive oil (Olea europaea L., fruit), food gelatin (capsule ingredient), homotaurine, glazing agents: hydroxypropyl methylcellulose, shellac; anti-caking agents: silicon dioxide; antioxidant: DL-alpha-tocopherol; stabilizer: glycerol; extracyan black blueberry (Vaccinium myrtillus L., fruit) dry extract; colorants: iron oxide, titanium dioxide; quatrefolic [(6S)-5-methyltetrahydrofolic acid, glucosamine salt].
Directions for use
Take 1 capsule per day.
Format
20 liquid-filled capsules.
Code. FBH0002
-DHF: dihydrofolate
-THF: tetrahydrofolate
-5,10-METHF: 5,10-Methyltetrahydrofolate
-5-METHF: Methyltetrahydrofolate
-MTHFR: Methylenetetrahydrofolate reductase
-P5P: Pyridoxal-5-phosphate
-R5P: Riboflavin-5-phosphate
Folate is of fundamental importance for the conversion of homocysteine to methionine.
Methylenetetrahydrofolate reductase (MTHFR) is the limiting enzyme in the methyl cycle that catalyzes the only biochemical reaction that produces 5-methyltetrahydrofolate (Quatrefolic), useful for reducing plasma homocysteine levels.
MTHFR C677T is a common MTHFR mutation with reduced catalytic activity, which leads to elevated plasma homocysteine levels, a common risk factor for cardiovascular disorders. A recent meta-analysis (published in June 2017) observed that patients with the MTHFR C677T mutation have a 30% higher risk of developing ischemic stroke.
Ingredients
Fish oil titrated in docosahexaenoic acid (DHA), extra virgin olive oil (Olea europaea L., fruit), food gelatin (capsule ingredient), homotaurine, glazing agents: hydroxypropyl methylcellulose, shellac; anti-caking agents: silicon dioxide; antioxidant: DL-alpha-tocopherol; stabilizer: glycerol; extracyan black blueberry (Vaccinium myrtillus L., fruit) dry extract; colorants: iron oxide, titanium dioxide; quatrefolic [(6S)-5-methyltetrahydrofolic acid, glucosamine salt].
Directions for use
Take 1 capsule per day.
Format
20 liquid-filled capsules.
Code. FBH0002

